New RSV vaccine shows promise for older adults in india

NCT ID NCT06614725

Completed ⭐️ VACCINE ⭐️ Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 3 study tested a single dose of an investigational RSV vaccine in 751 adults aged 60 and older, and those 50-59 at increased risk for severe RSV. The goal was to see how well the vaccine boosts the immune system and whether it is safe. Participants received either the vaccine or a placebo, and researchers measured antibody levels and tracked any side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: RSVPreF3 OA investigational vaccine
What this could lead to: If successful, this vaccine could help protect older adults and those at higher risk from severe RSV-related lung infections.
What could go wrong: This trial is completed but results are not yet published. The vaccine may not work as well in real-world settings or may cause side effects like pain or swelling at the injection site.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

respiratory syncytial virus infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RESPIRATORY SYNCYTIAL VIRUS INFECTIONS

Contacts and locations

Locations

GSK Investigational Site

Kanpur, Uttar Pradesh, 208002, India
GSK Investigational Site

Ahmedabad, 380015, India
GSK Investigational Site

Ahmedabad, 380061, India
GSK Investigational Site

Aligarh, 202002, India
GSK Investigational Site

Bangalore, 560002, India
GSK Investigational Site

Belagavi, 590019, India
GSK Investigational Site

Darjeeling, 734012, India
GSK Investigational Site

Delhi, 110060, India
GSK Investigational Site

Kelambākkam, 603103, India
GSK Investigational Site

Kochi, 682026, India
GSK Investigational Site

Kolkata, 700073, India
GSK Investigational Site

Pune-411 043, 411043, India
GSK Investigational Site

Raipur, India
GSK Investigational Site

Vadu Budruk Pune, 412216, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.